All Episodes
Small Stocks, Big Money — 157 episodes · page 1 of 2
Autonomous Navigation in GPS-Denied Environments | CEO Ben Williams on Exyn Technologies (EXYN)
8 Products, One Ore Body, $560/Ton Margin: CEO Mark Smith on NioCorp's Updated Feasibility Study
Tokenizing Wall Street: David Wachsman on Hawkeye Digital (OTC: HWKE)
RedChip Highlights Virax Biolabs Group (NASDAQ: VRAX) & TransCode Therapeutics (NASDAQ: RNAZ)
RedChip Highlights Nord Precious Metals Mining Inc.(OTCQB: NPMMF) &OBOOK Holdings Inc.(NASDAQ: OWLS)
RedChip Highlights Venu Holding Corporation (NYSE American: VENU) & Proactive Sustainable Bonds
RedChip Highlights Bimergen Energy(NYSE American: BESS) & Alliance Entertainment (NASDAQ: AENT)
Alliance Entertainment (Nasdaq: AENT): Building the Authentication Layer for Vinyl Collectors
CEO Frank Basa on Nord Precious Metals' (OTCQB: NPMMF) 29 Veins Inside of One Historic Silver Camp
Alliance Entertainment (Nasdaq: AENT): $1B Revenue, 33% Movie Growth & the Collectibles Shift
CEO Paul Mann on ASP Isotopes (Nasdaq: ASPI): 4 Facilities, $38B Market & Western Supply Security
Co-CEO Bob Brilon on Bimergen Energy's (NYSE: BESS) 23-Project Energy Arbitrage Pipeline
CEO Lavell Malloy on Brag House's (Nasdaq: TBH) Blockchain Sports Platform & Athlete Tokenization
CEO James Foster on Virax Biolabs' (VRAX) Long COVID Diagnostic & US Market Entry
Jeremy Schwartz CIO of WisdomTree ($WT): $165B AUM, Mega Trends & Why WT Is a Secular Growth Stock
First Phosphate (FRSPF) CEO on Agnico's $94M Bet Leaves Only 2 Independents Standing
Anixa Biosciences (ANIX): CEO on Breast Cancer Vaccine, Phase 2 Catalyst & Ovarian Cancer CAR-T Data
CEO Brandon Robinson on Horizon Aircraft’s (HOVR) Commercial eVTOL Advantages
First Phosphate (FRSPF) CEO on $16.7M Non-Dilutive Funding, LFP Batteries, and Why FRSPF Stands Out
RedChip Highlights Enlivex Therapeutics Ltd. (NASDAQ: ENLV) & Off The Hook Inc. (NYSE American: OTH)
SCAP Portfolio Manager Jay Hatfield’s Market Playbook: Fed Cuts, Core PCE, and Small Caps
Enlivex (Nasdaq: ENLV) - FY25 Financial Results Webcast Replay
Enlivex (ENLV) CEO: Two Pillars of Growth, Allocetra Knee OA Catalyst + RAIN Treasury Optionality
Off The Hook (NYSE American: OTH) CEO Interview: $145M Revenue Path, AI Boat Platform, Apex Upside
Comprehensive Healthcare Systems (CMHSF | CHS): CEO Interview on Healthcare SaaS and Pipeline Growth
The Metals Company (TMC) CFO Craig Shesky: The NOAA Path, $23.6B NPV, and US Supply Security
BioVie (Nasdaq: BIVI) CEO Cuong Do on Near Term Catalysts in Parkinson’s, Long COVID, and Ascites
First Phosphate CEO John Passalacqua: Building a North American LFP Battery Supply Chain (FRSPF)
Nexalin Technology (NXL) CEO Mark White: FDA Trials, At-Home Neurostimulation, and 2026 Milestones
OBOOK Holdings (OWLS) CEO Darren Wang on Regulated Stablecoin Payments, OwlPay Growth and 2026 Goals
NioCorp (NB) CEO Mark Smith on 2025 Milestones, Elk Creek Portal Buildout, and U.S. EXIM Financing
ASP Isotopes (Nasdaq: ASPI) Investor Webinar - January 14, 2026
Avalon Advanced Materials CEO Interview | $4B Lithium Opportunity + Rare Earth Supply Chain Upside
Alliance Entertainment (NASDAQ: AENT) Chairman on Earnings Growth and Exclusive IP Strategy
Processa Pharmaceuticals (PCSA) Interview: Phase 2 Breast Cancer Data, Pipeline Strategy & FDA Path
New Era (Nasdaq: NUAI) CEO Discusses Power, AI Data Centers, and the Next Phase of Growth
NioCorp CEO Mark Smith on U.S. Critical Minerals, Scandium Demand, and Project Financing Progress
Nova Minerals CEO: $43.4M U.S. Funding Secured, Antimony Production by 2026 and 5.2Moz Gold Resource
BullFrog AI CEO Vin Singh: Using AI to Transform Drug Discovery and Cut Development Costs
Jackpot Digital CEO Jake Kalpakian on Disrupting the Casino Industry with Dealerless Poker Tech
Connect Biopharma CEO Barry Quart: Targeting a $5B+ Market with a Next-Gen Asthma & COPD Therapy
FatPipe Networks: CEO Dr. Ragula Bhaskar on Scaling Profitable Growth in SD-WAN and Cybersecurity
60 Degrees Pharmaceuticals: CEO Geoff Dow on Breakthrough Babesiosis Therapy & FDA Path Ahead
Inside Bimergen Energy: $250M Equity Backing & 2GW BESS Pipeline with CFO Bob Brilon
Inside Nexalin: Drug-Free Neuro Tech, Clinical Milestones, and What’s Next!
Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development
Foremost Clean Energy CEO on Nuclear's Resurgence & 330K Acre Uranium Portfolio
PhoenixEV CEO John Walsh Interview: 2025 Goals, $200M Backlog and Transit Growth
Inside 60 Degrees Pharmaceuticals: CEO Geoffrey Dow on Revenue Growth & Pipeline Potential
Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe
Investor Insights: Calidi CEO Eric Poma Discusses Breakthroughs in Oncolytic Virotherapy
Precision Oncology at Scale: Lantern Pharma’s Strategic Vision with CEO Panna Sharma
Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook
Inside Processa Pharma: CEO George Ng on Disrupting Oncology Drug Development
Greenwich LifeSciences' CEO on Advancing HER2+ Immunotherapy | Phase III Insights & Strategy
How Fathom Holdings Is Disrupting Real Estate with Tech & Flat-Fee Innovation | CEO Marco Fregenal
ASP Isotopes CEO Paul Mann on Transforming Global Isotope Supply for Medicine, Clean Energy, & More!
Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive
Inside 60 Degrees Pharma: CEO Geoffrey Dow on Fighting Infectious Diseases & Driving Growth
Uranium & Lithium Boom: Foremost Clean Energy CEO on the Future of North America's Supply
FatPipe (Nasdaq: FATN) CEO Talks Profitability, Patented Tech & Global Growth Strategy
BioVie CEO Cuong Do on Alzheimer’s Breakthroughs, Liver Disease Pipeline & What’s Ahead
Liberty Star Minerals: Leadership Breaks Down High-Grade Gold & Copper Potential in Arizona
Inside Atossa Therapeutics (Nasdaq: ATOS): CEO Dr. Steven Quay on Advancing Breast Cancer Treatment
Inside ConnectM: How AI Is Powering the $2 Trillion Electrification Boom
bioAffinity (Nasdaq: BIAF) CEO Maria Zannes Talks CyPath® Lung, Growth & AI Innovation
Interview with Connect Biopharma CEO Barry Quart | Transforming Acute Asthma & COPD Care
BullFrog AI CEO Vin Singh on Revolutionizing Drug Development with AI-Powered Insights
LiveOne (Nasdaq: LVO) CEO Robert Ellin on Disrupting Music, Media & Monetization
Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential
Inside Knightscope (Nasdaq: KSCP): CEO William Santana Li on AI, Robotics & Crime Prevention
Jupiter Neurosciences CEO Christer Rosén on Advancing Neuroinflammation Treatments & Beyond
Alliance Entertainment: Inside The Billion-Dollar Giant Powering Media Distribution Globally
Inside Calidi Biotherapeutics: CFO Andrew Jackson Breaks Down the Future of Oncolytic Virotherapy
60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoffrey Dow on Expanding Malaria Prevention & Beyond
Elevating Fan-Owned Live Entertainment: VENU Founder & CEO J.W. Roth Shares His Disruptive Approach
ASP Isotopes CEO Paul Mann on Breakthrough Isotope Tech, Quantum Computing & 2025 Growth Plans
Inside Enlivex: Oren Hershkovitz on Tackling Sepsis, Osteoarthritis, and Beyond with Allocetra™
Inside Gorilla Technology: CEO Jay Chandan & Interim CFO Bruce Bower on Smart Cities & Big Data
Inside OKYO Pharma’s (NASDAQ: OKYO) Phase 2 Trials with CEO Dr. Gary Jacob
Inside VSee Health’s Telehealth Revolution: Exclusive Interview with Co-CEO Dr. Imo Aisiku
Inside Can-Fite BioPharma’s (NASDAQ: CANF) Clinical Pipeline with CEO Motti Farbstein
How MUSQ ETF is Reshaping Music Investments: CEO David Shulhof Explains
The Future of Oncology: Calidi’s Stem Cell-Based Platforms for Fighting Cancer
How Alliance Entertainment (Nasdaq AENT) is Optimizing Operations for Continued Margin Improvement
The Gold Rush of 2024: Christopher Gerteisen’s Vision for Nova Minerals and Beyond
Interview with Founder of MUSQ Global Music Industry ETF
CEO Interview: ASP Isotopes is Commercializing New Isotope Enrichment Technology
CEO Interview: Discover How OKYO Pharma is Targeting the Multi-Billion-Dollar Dry Eye Disease Market
Learn Why Soligenix has Received $60M+ in Non-Dilutive Funding From the US Government: CEO Interview
Pioneering New Osteosarcoma and Breast Cancer Treatments: Exclusive Interview with OS Therapies' CEO
CEO INTERVIEW: American Resources Corporation's Unique Ability to Refine Critical Elements
GreenPower Leverages Government Mandates and Funding to Boost Zero-Emission School Bus Line Growth
Discover Nexalin's Neurostimulation Device Targeting Mental Health Disorders
Biotricity CEO, Waqaas Al-Siddiq, on New Heart Health Innovations & the Future of Cardiac Care
Hope for Lung Cancer Patients: Cypath Lung Test's Impact
Alta Global Group: Converting MMA fans into Participants. An Interview with CEO Nick Langton
Exploring Can-Fite BioPharma's Groundbreaking Drugs: Piclidenoson and Namodenoson
Unlocking Hope: The BioVie Journey in Neurodegeneration and Liver Disease
AI Solutions in the Online CBD Industry: A 1606 Corp. Perspective